Average Ratings 1 Rating
Average Ratings 0 Ratings
Description
Argumont is an online decision intelligence tool designed for organizations faced with significant choices, including vendor selection, contract renewals, risk management, capital distribution, and strategic planning. It organizes the decision-making process by outlining the central question, available options, evaluation criteria, constraints, and critical uncertainties, while also designating analytical roles to develop and scrutinize competing arguments. The platform allows users to gather external information, evaluate evidence, examine assumptions and risks, compare different options, and ultimately generate a detailed Verdict that includes reasoning and acknowledges uncertainties. Users maintain the ultimate authority to make or endorse the final decision. Additionally, Argumont keeps a comprehensive record of the decision-making process, which encompasses evidence, challenges, approvals, and outcomes, and offers a downloadable Decision Passport for convenience. This innovative product primarily targets financial institutions and enterprise teams that require thorough documentation and the ability to revisit high-stakes decisions over time. By facilitating a structured approach to complex decisions, Argumont enhances transparency and accountability within organizations.
Description
EquiReason serves as a comprehensive platform for equity research and market intelligence, catering to self-directed investors, independent analysts, and research teams alike. By integrating SEC filings, XBRL financial data, earnings-call transcripts, and extensive market information, it empowers users to analyze financial performance, ownership trends, and overall company exposure. The platform meticulously tracks market events through economic channels, linking them to potentially impacted companies and offering a verdict for each, complete with supporting and counter-arguments. Users can access a variety of research perspectives, which include financial statements, valuation insights, insider and institutional activities, segment revenue details, and alerts specific to each company, with all evidence connected to its original source. Accessible via both web and iPhone app, EquiReason features a free plan alongside paid research options, ensuring users have the necessary tools for informed decision-making. Importantly, the platform focuses on providing research and decision support rather than direct investment advice, enabling users to navigate the complexities of the market with greater confidence.
API Access
Has API
No
API Access
Has API
Yes
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
$0
Free Trial
Yes
Free Version
Yes
Pricing Details
$49/month
Free plan available. Analyst is $49/month; Research Pro is $89/month. Annual billing is ten months for twelve. Research Pro has a seven-day trial with no card required.
Free Trial
Yes
Free Version
Yes
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
Yes
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
Argumont
Country
United States
Website
argumont.com
Vendor Details
Company Name
EquiReason
Founded
2026
Country
Turkey
Website
equireason.com
Product Features
Decision Support
Application Development
No
Budgeting & Forecasting
No
Data Analysis
No
Decision Tree Analysis
No
Monte Carlo Simulation
No
Performance Metrics
No
Rules-Based Workflow
No
Sensitivity Analysis
No
Thematic Mapping
No
Version Control
No